BioAge Labs, Net Worth
BioAge Labs, Net Worth Breakdown | BIOA |
BioAge Labs, Net Worth Analysis
BioAge Labs,'s net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including BioAge Labs,'s financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of BioAge Labs,'s overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform BioAge Labs,'s net worth analysis. One common approach is to calculate BioAge Labs,'s market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares BioAge Labs,'s stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing BioAge Labs,'s net worth. This approach calculates the present value of BioAge Labs,'s future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of BioAge Labs,'s cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate BioAge Labs,'s net worth. This involves comparing BioAge Labs,'s financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into BioAge Labs,'s net worth relative to its peers.
Enterprise Value |
|
To determine if BioAge Labs, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding BioAge Labs,'s net worth research are outlined below:
BioAge Labs, had very high historical volatility over the last 90 days | |
BioAge Labs, has a very high chance of going through financial distress in the upcoming years | |
BioAge Labs, has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
Net Loss for the year was (63.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
BioAge Labs, currently holds about 4.63 M in cash with (37.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
Latest headline from gurufocus.com: BioAge Labs to Present at Upcoming Investor Conferences |
BioAge Labs, Quarterly Good Will |
|
Follow BioAge Labs,'s market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 674.12 M.Market Cap |
|
Project BioAge Labs,'s profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.46) | (2.34) | |
Return On Capital Employed | 1.50 | 1.58 | |
Return On Assets | (2.46) | (2.34) | |
Return On Equity | 0.37 | 0.39 |
When accessing BioAge Labs,'s net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures BioAge Labs,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of BioAge Labs,'s profitability and make more informed investment decisions.
Please note, the presentation of BioAge Labs,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioAge Labs,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioAge Labs,'s management manipulating its earnings.
BioAge Labs, Corporate Filings
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 4th of October 2024 The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act | ViewVerify |
F4 | 3rd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
BioAge Labs, Earnings per Share Projection vs Actual
BioAge Labs, Corporate Management
MD MBA | Chief Officer | Profile | |
Justin Rebo | Senior Biology | Profile | |
Rusty Montgomery | Senior Research | Profile | |
Paul MD | Chief Research | Profile | |
Peng MBA | Chief Aging | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs,. If investors know BioAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAge Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.40) |
The market value of BioAge Labs, is measured differently than its book value, which is the value of BioAge that is recorded on the company's balance sheet. Investors also form their own opinion of BioAge Labs,'s value that differs from its market value or its book value, called intrinsic value, which is BioAge Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAge Labs,'s market value can be influenced by many factors that don't directly affect BioAge Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAge Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAge Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAge Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.